In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Anavex Life Sciences (AVXL – Research Report), with a price target of $40.00. The company's shares closed last Friday at $10.26. According to TipRanks.com, Roy is a 3-star analyst with an average return of 3.6% and a 30.4% success rate. Roy covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Adaptimmune Therapeutics, and Monopar Therapeutics Inc. Currently, the analyst consensus on Anavex Life Sciences is a Strong Buy with an average price target of $35.20, representing a 243.1% upside.
https://www.tipranks.com/news/blurbs/anavex-life-sciences-avxl-gets-a-buy-rating-from-jonestrading?utm_source=advfn.com&utm_medium=referral
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Anavex Life Sciences Charts.
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Anavex Life Sciences Charts.